Control of chemotherapy-induced diarrhoea with octreotide in patients receiving 5-fluorouracil

This publication has 11 references indexed in Scilit:

• Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma assessment of activity and toxicity
  Cancer, 1990
• Phase II study of fluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinoma.
  Journal of Clinical Oncology, 1990
• Treatment of endocrine and nonendocrine secretory diarrheal states with Sandostatin®
  Metabolism, 1990
• THE SOMATOSTATIN ANALOG OCTREOTIDE IN THE MANAGEMENT OF THE SECRETORY DIARRHEA OF THE ACUTE INTESTINAL GRAFT-VERSUS-HOST DISEASE IN A PATIENT AFTER BONE MARROW TRANSPLANTATION
  Transplantation, 1990
• Treatment of secretory diarrhea in AIDS with the somatostatin analogue SMS 201-995
  Journal of Molecular Medicine, 1989
• Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancer
  Cancer, 1989
• In vitro effects of the long-acting somatostatin analogue SMS 201–995 on electrolyte transport by the rabbit ileum
  Gastroenterology, 1988
• Remission of symptoms during long term treatment of metastatic pancreatic endocrine tumours with long acting somatostatin analogue.
  BMJ, 1986
• PROLONGED TREATMENT OF ZOLLINGER-ELLISON SYNDROME BY LONG-ACTING SOMATOSTATIN
  The Lancet, 1986
• Use of a long acting somatostatin analogue in controlling life threatening ileostomy diarrhoea.
  BMJ, 1984